Skip to main content

Cancer in Ireland

Cancer is a major public health issue and is the leading cause of death in adults in Ireland, with an estimated 1 in 2 individuals expected to receive a cancer diagnosis in their lifetime. As the Irish population grows and ages, the number of people diagnosed with invasive cancer every year is expected to grow by between 50% and 100% over the 30-year period from 2015 to 2045. NCRI's comprehensive cancer data provides vital statistics and insights to inform research, enhance public health initiatives, and improve patient outcomes across Ireland.

Statistics from NCRI's most recent report

  • 26,528
    Invasive tumours xNMSC per year
  • 10,258
    Deaths per year
  • 1 in 2
    Lifetime risk

Most common

  • Prostate
  • Breast
  • Lung
  • Colorectal

Men

Prostate
32%
Colorectal
12%
Lung
11%

Women

Breast
33%
Lung
11%
Colorectal
10%

Deaths in Ireland

Top causes of death as per recent report
  • Lung
  • Breast
  • Colorectal
  • Prostate

Men

Lung
20%
Prostate
12%
Colorectal
11%

Women

Lung
20%
Breast
16%
Colorectal
10%
Annual Stats Report 2026 Cover

Annual Statistical Report | 2026

Cancer in Ireland 1994-2023

An average of 46,800 tumours were diagnosed each year during 2020-2023. The majority of these (26,500) were life-changing invasive cancers. 

On average 10,300 people died each year from cancer during 2020-2023. One in five deaths were due to lung cancer. 

Survival rates for some cancers can be as high as 95% five years after diagnosis

More than 30 years of NCRI data show sustained improvements in cancer survival and reduced mortality

Cancer in Ireland 1994-2023

Covid 19 Report cover

Covid - 19 Impact Report | 2025

2025

No consistent rise in late-stage cancers 

was observed following the pandemic

Survival rates for all cancer sites 

in 2020–2021 remained in line with previous years

Cancer diagnoses did drop sharply (27%) in early 2020 

as Covid-19 disrupted health services

The health system reconfigured quickly during the pandemic and recovered quickly

 

By 2022 the number of diagnosed cases had returned to expected levels

2025